Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion XL vs Escitalopram in MDD
NCT02191397Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in major depressive disorder (MDD), sponsored by GSK. Started Feb 2015; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02191397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191397.